the naltrexone challenges produced no increase in opioid withdrawal symptoms , plasma mhpg levels , or blood pressure compared to placebo , while naloxone produced significant symptoms and blood pressure increases compared to placebo challenges .
C0027360
naltrexone
C0027358
naloxone